KYORIN Pharmaceutical (4569) · FactRestated
Appointment of a Female Director
First written in FY2019. 1 of 2 entries say "Restated". Latest entry: FY2024.
2entries
6years
0from disclosures
How it moved
Same theme, other companies
Board diversification through the appointment of a female directorA theme 7 companies write about · 0 as a headwind · 7 as a tailwind
0 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024RestatedAnnual report
「From a diversity perspective, the company also appoints 1 female director.」
The company continues to maintain a structure that includes 1 female director from a diversity perspective. - FY2019First statedAnnual report
「From the perspective of diversity, we have also appointed 1 female director.」
The Company discloses the appointment of 1 female director as part of the Board’s composition.